Postvaricella purpura fulminans;Púrpura fulminante posvaricelosa

Anales de Pediatria

Volumn 60, Issue 6, 2004, Pages 585-588

  Manrique De Lara, L Alsina ^a,b   Zambudio Sert, S ^a   Piza Oliveras A ^a   Toll Costa, T ^a   Garcia Garcia J J ^a   Luaces Cubells, C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Sant Joan de Deu   (Spain)

Author keywords

Antiprotein S antibodies; Protein S; Purpura fulminans; Varicella

Indexed keywords

PROTEIN S;

ARTICLE; CASE REPORT; CHICKENPOX; CLINICAL FEATURE; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ECCHYMOSIS; FEMALE; FULMINATING PURPURA; HUMAN; MALE; POSTVARICELLA PURPURA FULMINANS; PRESCHOOL CHILD; PURPURA;

EID: 3242890782     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13062329     Document Type: Article

References (22)

1. Pérez-Yarza EG, Arranz L, Alustiza J, Azkunaga B, Uriz J, Sarasua A, y Grupo Varicela Gipuzkoa. Hospitalizaciones por complicaciones de la varicela en niños menores de 15 años. An Pediatr (Barc) 2003;59:229-33.
2. Levin M, Eley BS, Louis J, Cohen H, Young L, Heyderman RS. Postinfectious purpura fulminans caused by an antibody directed against protein S. J Pediatr 1995;127:355-63.
3. Van Ommen CH, Van Wijnen M, De Groot FG, Van der Horst CM, Peters M. Postvaricella purpura fulminans caused by acquired protein S deficiency resulting from antiprotein S antibodies: Search for the epitopes. Pediatr Hematol Oncol 2002;24:413-6.
4. Ángeles Fernández G, Villanueva Lamas J, Cambra FJ, Toll Costa T, Palomeque Rico A. Púrpura fulminans postvaricelosa con déficit transitorio de proteína C y proteína S. An Esp Pediatr 1998;49:412-4.
5. Toll Costa T, Estella Aguado J, Youssef Fasheh W, Bello Mayoraz J. Púrpura fulminans An Esp Pediatr 1992;36:481-3.
6. Phillips WG, Marsden JR, Hill FG. Purpura fulminans due to protein S deficiency following chickenpox. Br J Dermatol 1992;127:30-2.
7. Francis RB Jr. Acquired purpura fulminans. Semin Thromb Hemost 1990;16:310-25.
8. Leclerc F, Hazelzet J, Jude B, Hofhuis W, Hue V, Martinot A, et al. Protein C and S deficiency in severe infectious purpura of children: A collaborative study of 40 cases. Intensive Care Med 1992;18:202-5.
9. Adrock DM, Brozna J, Marlar RA. Proposed classification and pathologic mechanisms of purpura fulminans and skin necrosis. Semin Thromb Hemost 1990;16:333-40.
10. Borgel D, Gandrille S, Aiach M. Protein S deficiency. Thromb Hemost 1997;78:351-6.
11. Powars DR, Rogers ZR, Patch MJ, McGehee WG, Francis RB. Purpura fulminans in menigococcaemia: association with acquired deficiencies of protein C and S. N Engl J Med 1987;317:571-2.
12. Manco-Johnson MJ, Nuss R, Key N, Moertel C, Jacobson L, Meech S, et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996;128:319-23.
13. Nguyen P, Reynaud J, Pouzol P, Munzer M, Richard O, François P. Varicella and thrombotic complications associated with transient protein C and protein S deficiencies in children. Eur J Pediatr 1994;153:646-9.
14. De Frutos Martínez C, Iturrioz Mata A, González Pérez-Yarza E, Arratibel Fuentes Ma.C, Sainz Arroniz R, Albisu Andrade Y. Púrpura fulminante idiopática con déficit transitorio de proteína S. An Esp Pediatr 2001;55:369-73.
15. Josephson C, Russ R, Jacobson L, Hacker MR, Murphy J, Weinberg A, et al. The varicella autoantibody syndrome. Ped Res 2001;50:345-52.
16. Kurugöl Z, Vardar F, Özkinay F, Kavakli K, Özkinay C. Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infection. Acta Paediatr 2000;89:1186-9.
17. Sorice M, Griggi T, Arcieri P, Circella A, d'Agostino F, Ranieri M, et al. Protein S and HIV infection. The role of anticardiolipin and antiprotein S antibodies. Thomb Res 1994;73:165-75.
18. Woods CR, Johnson CA. Varicella purpura fulminans, associated with heterozygosity for factor V Leiden and transient protein S deficiency. Pediatrics 1998;102:1208-10.
19. Al-Ismail S, Collins P, Najib R, James-Ellison M, O'Hagan M. Postinfection purpura fulminans in a patient heterozygous for prothrombin G20210A and acquired protein S resistance. Pediatr Hematol Oncol 1999;16:561-4.
20. Reinert P. Épidémiologie du purpura fulminans et recommandations thérapeutiques actuelles. Arch Pédiatr 2001:8(Suppl 4):673-6.
21. Hattersley PG. Purpura fulminans: Complete recovery with intravenously administered heparin. Am J Dis Child 1970;120:467-71.
22. Kuppermann N, Hinkelis S, Saladino R. The role of heparin in the prevention of extremity and digit necrosis in meningococcal purpura fulminans. Pediatr Infect Dis J 1994;13:867-73.